tiprankstipranks
Viking Therapeutics (VKTX)
NASDAQ:VKTX
US Market
VKTX
Viking Therapeutics
RESEARCH TOOLSreports
Want to see VKTX full AI Analyst Report?

Viking Therapeutics (VKTX) Stock News & Sentiment

7,411 Followers
Viking Therapeutics Maintained at Buy as VK2735 Advances Through Phase 3, Price Target Reaffirmed at $102
Premium
Ratings
Viking Therapeutics Maintained at Buy as VK2735 Advances Through Phase 3, Price Target Reaffirmed at $102
3d ago
VKTX
VKTX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
VKTX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
7d ago
VKTX
3 Best Stocks Under $50 to Buy in April 2026, According to Analysts
Premium
Market News
3 Best Stocks Under $50 to Buy in April 2026, According to Analysts
1M ago
FIGR
ONON
Viking Therapeutics: Accelerated VK2735 Obesity Program and Single‑Molecule Strategy Support Buy Rating and Favorable Risk‑Reward
Premium
Ratings
Viking Therapeutics: Accelerated VK2735 Obesity Program and Single‑Molecule Strategy Support Buy Rating and Favorable Risk‑Reward
1M ago
VKTX
Strong Enrollment and Phase 3 Momentum Underpin Buy Rating on Viking Therapeutics’ Obesity Program
Premium
Ratings
Strong Enrollment and Phase 3 Momentum Underpin Buy Rating on Viking Therapeutics’ Obesity Program
1M ago
VKTX
T-Mobile, AppLovin, ConocoPhillips, Viking, Western Digital Insider Shake-Up
Premium
Weekend Updates
T-Mobile, AppLovin, ConocoPhillips, Viking, Western Digital Insider Shake-Up
2M ago
APP
COP
Maintained Buy Rating on Viking Therapeutics Reflects Confidence in Pipeline Strength and Favorable Risk‑Reward Profile
Premium
Ratings
Maintained Buy Rating on Viking Therapeutics Reflects Confidence in Pipeline Strength and Favorable Risk‑Reward Profile
2M ago
VKTX
More VKTX News >

VKTX News on the Web

Is Viking Therapeutics the Ultimate Millionaire-Maker Obesity Stock for 2026?
The Motley Fool
Neutral
Viking Therapeutics, Inc. (VKTX) Exceeds Market Returns: Some Facts to Consider
Zacks
Bearish
Does NVO Face Rising Competitive Pressure on LLY's Foundayo Approval?
Zacks
Neutral
Is Viking Therapeutics (VKTX) a Buy as Wall Street Analysts Look Optimistic?
Zacks
Neutral
Viking Therapeutics, Inc. (VKTX) Surpasses Market Returns: Some Facts Worth Knowing
Zacks
Bearish
NVO Crashes 36% in 3 Months: Is This an Indication to Sell the Stock?
Zacks
Neutral
LLY Launches GLP-1 Pill, Expands Access Through Pharmacy Partnerships
Zacks
Neutral
Viking Therapeutics call volume above normal and directionally bullish
TipRanks News
Bullish

News Score - Last 7 Days

Neutral
VKTX
Sector Average
Media Buzz
This Week4 articles
Weekly Average8.25 articles
News Sentiment
This Week0%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is VKTX’s Media Buzz Sentiment?
4 articles about VKTX were published this week. In an average week, 8.25 articles are published.
    What is VKTX’s weekly average amount of articles?
    In an average week, 8.25 articles about VKTX are published.
      What is VKTX’s News Sentiment?
      Currently, no data Available
      Healthcare Stocks that are Trending in the News
      TVTXTravere Therapeutics
      HVOOpen Orphan Plc
      PBMPsyence Biomedical
      QDELQuidelOrtho
      Showing the stocks with the most bullish news sentiment over the past week